| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0e8b499ea28bb81a70c1cd51c3df89e7 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-627
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6087
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-6037 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-33
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-08 |
| filingDate |
2020-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_13db932052cf1e632a08429211dc7772
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e925867679a0accd1604c14d21a5b38
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f43b02478934182b44492a76a94e718
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_aab60bae047dc8abf21acd53e1086a0d |
| publicationDate |
2022-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-4021491-A1 |
| titleOfInvention |
Antimicrobial vaccine compositions |
| abstract |
This invention is directed to antimicrobial vaccine compounds and compositions comprising oligosaccharide β-(1→6)- glucosamine groups having from 3 to 12 glucosamine units linked through a linker group to tetanus toxoid wherein the toxoid is primarily in its monomeric form This invention is also directed to vaccine compositions that provide natural immunity against microbes possessing a cell wall structure tha comprises oligosaccharide N-acetyl-β-(1→6)-glucosamine (PNAGJ structures. |
| priorityDate |
2019-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |